Pure Global

AyoTes QD Based Glycosylated Hemoglobin (HbA1c) - Indonesia BPOM Medical Device Registration

AyoTes QD Based Glycosylated Hemoglobin (HbA1c) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207320440. The device is manufactured by CHONGQING ISIA BIO-TECHNOLOGY CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. HEALTHY FAMILY FOCUS.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
AyoTes QD Based Glycosylated Hemoglobin (HbA1c)
Analysis ID: AKL 20207320440

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. HEALTHY FAMILY FOCUS

AR Address

Komplek Delta Building Blok B 1-2, Jalan Suryopranoto No. 1-9, Prov. DKI Jakarta, Kota Jakarta Pusat, Kec. Gambir, Kel. Petojo Selatan

Registration Date

Nov 08, 2023

Expiry Date

Nov 08, 2026

Product Type

Haematology Package and Kit

Glycosylated hemoglobin assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing